SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-006021
Filing Date
2020-05-08
Accepted
2020-05-08 16:32:45
Documents
61
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tbph-20200508x10q.htm   iXBRL 10-Q 1571704
2 EX-10.1 tbph-20200331xex10d1.htm EX-10.1 43291
3 EX-10.2 tbph-20200331xex10d2.htm EX-10.2 243552
4 EX-10.3 tbph-20200331xex10d3.htm EX-10.3 48360
5 EX-31.1 tbph-20200331xex31d1.htm EX-31.1 14915
6 EX-31.2 tbph-20200331xex31d2.htm EX-31.2 15699
7 EX-32 tbph-20200331xex32.htm EX-32 17721
8 GRAPHIC tbph-20200331xex10d1g001.jpg GRAPHIC 743749
9 GRAPHIC tbph-20200331xex10d2g001.jpg GRAPHIC 743749
  Complete submission text file 0001558370-20-006021.txt   7983401

Data Files

Seq Description Document Type Size
10 EX-101.SCH tbph-20200508.xsd EX-101.SCH 38655
11 EX-101.CAL tbph-20200508_cal.xml EX-101.CAL 46791
12 EX-101.DEF tbph-20200508_def.xml EX-101.DEF 132985
13 EX-101.LAB tbph-20200508_lab.xml EX-101.LAB 362264
14 EX-101.PRE tbph-20200508_pre.xml EX-101.PRE 267576
45 EXTRACTED XBRL INSTANCE DOCUMENT tbph-20200508x10q_htm.xml XML 898507
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36033 | Film No.: 20861090
SIC: 2834 Pharmaceutical Preparations